FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,985,325 | -55.1% | 1,386,058 | -0.4% | 0.11% | -56.5% |
| Q3 2022 | $31,177,000 | -29.9% | 1,391,217 | -22.5% | 0.25% | -29.1% |
| Q2 2022 | $44,461,000 | -6.0% | 1,794,248 | +47.0% | 0.35% | +15.5% |
| Q1 2022 | $47,312,000 | +68.6% | 1,220,321 | +154.4% | 0.30% | +81.4% |
| Q4 2021 | $28,064,000 | +62.7% | 479,648 | +64.8% | 0.17% | +60.6% |
| Q3 2021 | $17,254,000 | -34.1% | 291,101 | -3.5% | 0.10% | -33.8% |
| Q2 2021 | $26,180,000 | +23.7% | 301,651 | +17.5% | 0.16% | +18.9% |
| Q1 2021 | $21,166,000 | +45.8% | 256,717 | +60.8% | 0.13% | +53.5% |
| Q4 2020 | $14,516,000 | -11.5% | 159,639 | -61.1% | 0.09% | -18.9% |
| Q3 2020 | $16,401,000 | +9.1% | 410,329 | -6.4% | 0.11% | +2.9% |
| Q2 2020 | $15,039,000 | +64.3% | 438,323 | +6.4% | 0.10% | +27.2% |
| Q1 2020 | $9,153,000 | -33.6% | 412,096 | -41.5% | 0.08% | -17.3% |
| Q4 2019 | $13,794,000 | -1.9% | 704,843 | -22.2% | 0.10% | -13.3% |
| Q3 2019 | $14,064,000 | -19.3% | 905,619 | +5.5% | 0.11% | -13.7% |
| Q2 2019 | $17,433,000 | +11.1% | 858,749 | -3.9% | 0.13% | +10.1% |
| Q1 2019 | $15,697,000 | +10.8% | 893,425 | -19.1% | 0.12% | -1.7% |
| Q4 2018 | $14,168,000 | +4.5% | 1,104,305 | +32.7% | 0.12% | +27.4% |
| Q3 2018 | $13,554,000 | +48.4% | 832,070 | +3.3% | 0.10% | +39.7% |
| Q2 2018 | $9,134,000 | – | 805,460 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |